hydroxyurea has been researched along with Atypical Ductal Hyperplasia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a rare case of secondary breast carcinoma after chronic myeloid leukemia (CML) in a 56-year-old woman." | 1.46 | Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy. ( Bi, L; Duan, J; Fan, Z; Pan, L; Qiao, W; Wu, D; Yang, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, L | 1 |
| Duan, J | 1 |
| Qiao, W | 1 |
| Bi, L | 1 |
| Wu, D | 1 |
| Fan, Z | 1 |
| Yang, M | 1 |
1 other study available for hydroxyurea and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Car | 2017 |